What happens when you take esomeprazole with vitamin b12?
Esomeprazole (Nexium) is the S-enantiomer of omeprazole. It tends to produce somewhat more consistent acid suppression than racemic omeprazole, but its effect on vitamin B12 is the same as other PPIs. Here is the chain of events:
- Esomeprazole shuts down stomach acid. It blocks the H+/K+ ATPase "proton pump" in the stomach's parietal cells, sharply reducing acid output at standard doses.
- Food-bound B12 needs acid to be released. Vitamin B12 in food is bound to animal proteins. Stomach acid and the enzyme pepsin normally cleave it free so it can bind intrinsic factor and be absorbed further down the gut.
- Less acid means less B12 freed from food. With acid suppressed, the protein-cleavage step is impaired and a fraction of dietary B12 passes through unabsorbed.
- Supplemental B12 takes a different route. Crystalline B12 in pills, sublingual lozenges, and injections is already free of food protein. It absorbs through a pathway that does not depend on stomach acid, which is what makes this interaction manageable.
So the interaction affects food-bound B12 only. This is the key insight: the same drug that reduces absorption from food does not block absorption from a supplement.
Why is this important?
B12 deficiency develops slowly because the liver holds a multi-year reserve. By the time symptoms appear, the change has been building for a long time, and some neurological effects can be slow to reverse. Classic features include fatigue, anemia, a sore smooth tongue, tingling or numbness in the hands and feet, balance problems, and, in advanced cases, cognitive and spinal-cord effects.
The link between long-term PPI use and lower B12 is supported by large studies. A case-control analysis published in JAMA found that prolonged PPI use was associated with a higher likelihood of a new B12 deficiency diagnosis. A later cohort study reported lower B12 levels in long-term PPI users, and a review in Advances in Nutrition summarized the mechanism and clinical implications. The effect is modest at a population level and is most relevant with sustained use rather than short courses.
Risk is concentrated in: older adults (who often have age-related atrophic gastritis on top of the PPI effect), people on PPIs for an extended period, those also taking metformin (which independently lowers B12), vegetarians and vegans (lower baseline intake), people after bariatric surgery, and those with H. pylori or autoimmune atrophic gastritis.
What should you do?
This is straightforward to manage. The schedule below frames it around your treatment.
Before starting or early in long-term therapy: Mention to your prescriber if you are older, vegetarian or vegan, on metformin, or have had gastric surgery — these raise your baseline risk and may warrant a baseline B12 check.
Every day, while on esomeprazole: If you choose to supplement, take crystalline B12 (oral or sublingual). Timing relative to your esomeprazole dose does not matter, because supplemental B12 does not need stomach acid. Stay alert to subtle symptoms such as unexplained fatigue, brain fog, tingling in the feet, or balance changes.
After extended use, and periodically thereafter: Ask your clinician about checking your B12 status. If a level is borderline, a methylmalonic acid test can clarify whether you are truly low. If you are low or symptomatic, your clinician will recommend oral, sublingual, or injectable B12 as appropriate. Do not stop esomeprazole abruptly — rebound acid can worsen reflux; taper with medical guidance if discontinuing, and review whether a lower dose, an H2 blocker, or on-demand use could replace continuous therapy.
Which specific products are affected?
Esomeprazole is sold as Nexium (OTC and prescription), Nexium IV in hospitals, and generic esomeprazole magnesium. It is also combined with naproxen in Vimovo. All forms have the same effect on dietary B12 absorption with chronic use.
All other PPIs share the effect to varying degrees: omeprazole (Prilosec), lansoprazole (Prevacid), pantoprazole (Protonix), rabeprazole (AcipHex), and dexlansoprazole (Dexilant). H2 blockers (famotidine, cimetidine) suppress acid less profoundly but can still impair food-bound B12 absorption with prolonged use.
On the supplement side, all crystalline B12 forms work because they bypass the acid step: cyanocobalamin (standard, lowest cost), methylcobalamin, hydroxocobalamin (long-acting injectable), and adenosylcobalamin. Fortified foods such as cereals and plant milks typically use cyanocobalamin and absorb similarly to supplements.
The science behind it
The mechanism — acid suppression impairing the release of food-bound B12 — is standard gastric physiology, and the clinical association is documented in large datasets.
- Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442 (PMID 24327038). A large case-control cohort analysis (over 200,000 people) found that sustained PPI use was associated with a higher likelihood of a new vitamin B12 deficiency diagnosis; H2-blocker use showed a weaker association.
- Association of vitamin B12 deficiency with long-term PPI use: a cohort study. Ann Med Surg (Lond). 2022 (PMC9577826). A cohort study reporting lower B12 levels in long-term PPI users, including esomeprazole, compared with controls.
- Miller JW. Proton pump inhibitors, H2-receptor antagonists, metformin, and vitamin B-12 deficiency: clinical implications. Adv Nutr. 2018;9(4):511S-518S (PMC6054240). A review explaining why food-bound B12 absorption depends on gastric acid and why acid-suppressing drugs and metformin can lower B12 over time.
Taken together, these support a real but modest, use-duration-dependent effect — strong enough to justify monitoring during long-term therapy, not strong enough to warrant stopping a needed medication.
Frequently Asked Questions
Does esomeprazole block vitamin B12 supplements too?
No. The interaction only affects B12 bound to food proteins. Crystalline B12 in supplements, lozenges, and injections is already protein-free and absorbs without stomach acid, so esomeprazole does not block it.
Do I need to separate my B12 supplement from my esomeprazole dose?
No. Because supplemental B12 does not rely on gastric acid, you can take it at any time relative to your esomeprazole.
Will a short course of esomeprazole cause B12 deficiency?
It is very unlikely. The association is tied to sustained, long-term use, and the liver holds a substantial B12 reserve. Short courses are not a meaningful concern for B12.
Should I stop my esomeprazole to protect my B12?
No — not on your own. The interaction is manageable, and stopping abruptly can cause rebound acid and worse reflux. If you no longer need long-term acid suppression, taper down with your prescriber rather than quitting suddenly.
How would I know if my B12 is low?
Early signs can be subtle: unexplained fatigue, brain fog, tingling in the hands or feet, or balance changes. A blood test for B12, and a methylmalonic acid test if the result is borderline, can confirm it.
I also take metformin. Does that change things?
Yes, somewhat. Metformin independently lowers B12, so combining it with a long-term PPI adds to the effect. Mention both to your clinician so B12 monitoring can be planned accordingly.
Key takeaways
- Esomeprazole, like all PPIs, can impair absorption of food-bound vitamin B12 by suppressing the stomach acid that frees it from food proteins.
- The effect is real but modest and tied to long-term use; it is a reason to monitor, not to stop a needed medication.
- Crystalline B12 in supplements and injections bypasses the interaction entirely — it does not need stomach acid.
- If you take esomeprazole long-term, ask your clinician about periodically checking your B12 status, especially if you are older, vegetarian/vegan, post-bariatric, or also on metformin.
- Do not stop esomeprazole abruptly; taper with guidance and review whether you still need continuous therapy.